Deal Tracker · Deal types

M&A / Acquisition deals

16 m&a / acquisition deals across emerging pharma markets tracked by EPT, led by MENA, Africa, Global (LMICs) & Southeast Asia. Most active: DKSH, Alfasigma, Art Pharma & AUG Pharma. Latest: DKSH → Roche (M&A / Acquisition, 28 Oct 2026).

• DKSH → Roche
  M&A / Acquisition · Global (LMICs) · Undisclosed · 28 Oct 2026
• Sothema → Ramo Pharm
  M&A / Acquisition · MENA · $6m · 28 Oct 2026
• Rameda → Art Pharma
  M&A / Acquisition · MENA · $20m · 26 Oct 2026
• HarmeeCare Pharmaceuticals → Kilitch Estro Biotech
  M&A / Acquisition · Africa · $14m · 23 Oct 2026
• Laprophan → Polymedic
  M&A / Acquisition · Africa · 21 Oct 2026
• EastPharma → Sanofi
  M&A / Acquisition · Africa · 20 Oct 2026
• DKSH → NewBridge Pharmaceuticals
  M&A / Acquisition · MENA · $390m · 19 Oct 2026
• FM6I → MARBIO
  M&A / Acquisition · MENA · Undisclosed · 6 Oct 2026
• CFAO Healthcare → OPHAM
  M&A / Acquisition · Africa · Undisclosed · 31 Aug 2026
• Alfasigma → Nordic Pharma
  M&A / Acquisition · Global ex-US · See terms · 9 Aug 2026
• Servier → Pharma Capital
  M&A / Acquisition · MENA · Undisclosed · 23 Jul 2026
• Bausch Health → AUG Pharma
  M&A / Acquisition · GCC · Undisclosed · 12 Jul 2026
• Livzon → Imexpharm
  M&A / Acquisition · Southeast Asia · $221m · 11 May 2026
• Pfizer → Jamjoom Pharma
  M&A / Acquisition · MENA · Undisclosed · 27 Apr 2026
• Lotus Pharmaceutical → Sandoz Philippines
  M&A / Acquisition · Southeast Asia · Undisclosed · 3 Apr 2026
• Faes Farma → SIFI
  M&A / Acquisition · Global (LMICs) · $310m · 2 Sept 2025